AstraZeneca Reaffirms FY26 Outlook: Sees Total Rev Up Mid-To-High Single-Digit %, Core EPS Up Low Double-Digit % At CER

Loading news article.

AstraZeneca Reaffirms FY26 Outlook: Sees Total Rev Up Mid-To-High Single-Digit %, Core EPS Up Low Double-Digit % At CER | WAPE

Article summary